Sanjay Subramanian - Jul 15, 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Chief Financial Officer
Signature: /s/ Sanjay Subramanian
Stock symbol: OCGN
Transactions as of: Jul 15, 2021
Transactions value $: -$197,707
Form type: 4
Date filed: 7/16/2021, 04:01 PM
Previous filing: Jun 17, 2021
Next filing: Aug 18, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Options Exercise	$10.6K	+31.1K	+68.18%	$0.34	76.7K	Jul 15, 2021	Direct
transaction	OCGN	Common Stock	Sale	-$208K	-31.1K	-40.54%	$6.70	45.6K	Jul 15, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCGN	Options (Right to Buy)	Options Exercise	$0	-31.1K	-10.12%	$0.00	276K	Jul 15, 2021	Common Stock	31.1K	$0.34	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.66 to $6.77. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3	The options, initially representing a right to purchase a total of 369,256 shares, vest and become exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates.